Skip to main content
. 2023 Jan 14;29(2):241–256. doi: 10.3748/wjg.v29.i2.241

Table 1.

Criteria, grading, and incidence of abnormal liver function or injury

Ref.
Sample size
Study type
Criteria and grading of ALF or injury
Comments
Salık et al[5] 533 Retrospective study Liver biochemical parameters: ALT, AST, and TBiL > ULN. Liver injury: ALT and/or AST > 3 ULN, and/or TBiL > 3 ULN NA
Cai et al[6] 417 Retrospective, single-center study ALF: > ULN. Liver injury: ALT and/or AST > 3 ULN, ALP, GGT, and/or TBiL > 2 ULN 76.3% had ALF and 21.5% had liver injury during hospitalization
Fan et al[8] 148 Retrospective, single-center study Increased levels of ALT, AST, GGT, ALP, and total bilirubin 37.2% had ALF at hospital admission
Kulkarni et al[9] 20874 Meta-analysis ELC: AST or ALT > ULN. SLI: Any elevation of enzymes > ULN and bilirubin over 2 ULN ELC: 23.1% at initial presentation. 24.4% developed ELC during the illness
Xu et al[10] 1003 Retrospective cohort study Mild liver injury: 1-2 ULN. Moderate liver injury: 2-5 ULN. Significant liver injury: > 5 ULN Most patients with abnormal liver function parameters had mild elevations (1-2 ULN) at admission and peak hospitalization
Hundt et al[13] 1827 Retrospective observational cohort study ELC: AST, ALT, ALP, TBiL, albumin: > ULN ELC at pre-hospitalization (AST 25.9%, ALT 38.0%, ALP 56.8%, and TBiL 44.4%). Admission (AST 66.9%, ALT 41.6%, ALP 13.5%, and TBiL 4.3%). Peak hospitalization (AST 83.4%, ALT 61.6%, ALP 22.7%, and TBiL 16.1%)
Balderramo et al[14] 298 Multicenter study ALEx2: The elevation of at least one of the following: TBil, ALT, AST, GGT, or ALP > 2 ULN During admission, 29.2% out of 298 patients presented ALEx2
Phipps et al[19] 6913 Retrospective cohort study Mild: ALT 1-2 ULN. Moderate: ALT between 2-5 ULN. Severe: ALT > 5 ULN Among patients who tested positive, 45% had mild, 21% moderate, and 6.4% SLI
Wang et al[21] 156 Retrospective, 2-centers study Elevated aminotransferases 41.0% patients with elevated aminotransferases
Liu et al[22] 245 Retrospective, single-center study Mild liver dysfunction: AST ≥ ULN. Moderate liver dysfunction: AST ≥ ULN combined with any parameter being greater than the ULN values of ALT, GGT, and TBiL. Severe liver dysfunction: AST ≥ ULN combined with ALT ≥ 3 ULN and/or GGT, TBiL ≥ 2 ULN 43.7% experienced mild liver dysfunction, 40.4% experienced moderate liver dysfunction, and 20.4% experienced severe liver dysfunction
Chaibi et al[23] 281 Retrospective cohort study ALF: AST, ALT, GGT, ALP or TBil > ULN 36.3 % had liver dysfunctions. Only a minority of patients (6.4%) had perturbations above 5 times the ULN
Shousha et al[24] 547 Multicenter cohort study Liver injury: Transaminase > 3 ULN 26% and 32% of patients had elevated ALT and AST, respectively. 4.91 and 3.70%patients, respectively, had AST or ALT elevation > 3 ULN

ALEx2: Abnormal liver enzymes over twice the upper limit of normal; ALF: Abnormal liver function; ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ELC: Elevated liver chemistries; DBiL: Direct bilirubin; GGT: Gamma-glutamyl transferase; NA: Not available; TBil: Total bilirubin; ULN: Upper limit of normal.